Thermoresponsive Hydrogel

Thermoresponsive Hydrogel
Details:
The continuous chemical synthesis of thermoresponsive hydrogel utilizes block copolymers of poly(N-isopropylacrylamide) (PNIPAM), poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) (Pluronic/Poloxamer arrays), or modified deacetylated chitosan-glycerophosphate frameworks.

The polymer backbone features precise balance between hydrophilic amide/hydroxyl groups and hydrophobic isopropyl/propylene oxide domains.

Below the Lower Critical Solution Temperature (LCST), hydrogen bonding between water molecules and the polymer backbone dominates, maintaining a liquid phase.

As temperature rises past 32°C, thermal energy disrupts these hydrogen bonds, forcing the hydrophobic groups to aggregate and collapse into a solid physical network.

Synthesis and high-vacuum degassing execute strictly inside temperature-controlled jacketed reactors maintained at 15°C to prevent premature thermal gelation.

Automated filling into primary containers is performed under ISO Class 5 cleanroom conditions followed by low-temperature sterile processing.
Send Inquiry
Download
Description
Technical Parameters
 

OEM Thermoresponsive Hydrogel | LCST Phase Transition Gel | TOP-RANK

 

 

Wholesale thermoresponsive hydrogel for smart drug delivery, tissue engineering, and thermal wound care. Formulated with calibrated LCST (32°C-35.5°C) sol-gel kinetics and zero room-temp burst release.

 

Product Profile

 

Operating as a smart, temperature-sensitive biopolymer system, this thermoresponsive hydrogel undergoes a reversible sol-to-gel phase transition driven by thermal shifts. At ambient room temperatures (<25°C), the material exists as a low-viscosity liquid precursor capable of flowing through fine-gauge needles or filling deep, irregular wound cavities. Upon contact with human tissue or exposure to physiological body temperatures (32°C--37°C), the polymer chains collapse their hydration shells, undergoing rapid hydrophobic association to form a solid, elastic 3D gel matrix (G' > 25,000 Pa). This thermodynamic transition prevents liquid runoff, seals complex tissue topographies, and enables temperature-locked controlled release of active pharmaceutical ingredients (APIs). We supply this thermoresponsive matrix in bulk liquid containers, pre-filled dual-chamber syringes, and sterile squeeze tubes to pharmaceutical OEMs, advanced wound care brands, and tissue engineering developers.

 

Polymer Chemistry & Low-Temperature Compounding

 

The continuous chemical synthesis of thermoresponsive hydrogel utilizes block copolymers of poly(N-isopropylacrylamide) (PNIPAM), poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) (Pluronic/Poloxamer arrays), or modified deacetylated chitosan-glycerophosphate frameworks. The polymer backbone features precise balance between hydrophilic amide/hydroxyl groups and hydrophobic isopropyl/propylene oxide domains. Below the Lower Critical Solution Temperature (LCST), hydrogen bonding between water molecules and the polymer backbone dominates, maintaining a liquid phase. As temperature rises past 32°C, thermal energy disrupts these hydrogen bonds, forcing the hydrophobic groups to aggregate and collapse into a solid physical network. Synthesis and high-vacuum degassing execute strictly inside temperature-controlled jacketed reactors maintained at 15°C to prevent premature thermal gelation. Automated filling into primary containers is performed under ISO Class 5 cleanroom conditions followed by low-temperature sterile processing. 

 

Key Technical Assets

 

  • Calibrated LCST Sol-Gel Kinetics (Sub-45s In-Situ Thermal Gelation) 

    Extruding a fluid into deep, irregular tissue cavities or active bleeding sites risks liquid runoff before a conventional hydrogel can set. Our thermoresponsive matrix is chemically tuned to exhibit an LCST range between 32.0°C and 35.5°C. When the ambient precursor liquid (20°C) contacts tissue at 37°C, the heat transfer triggers an instantaneous molecular phase change, completing sol-to-gel transition in under 45 seconds. The matrix solidifies precisely to fit complex 3D tissue geometry, preventing liquid migration and sealing cavity boundaries without light-curing or chemical cross-linking agents.

     

  • Temperature-Locked Matrix Encapsulation (Zero Room-Temperature API Burst Leakage) 

    Premature drug diffusion or burst release during shelf storage or topical application reduces therapeutic efficacy and causes localized toxicity. Below its LCST, our polymer precursor holds dissolved or suspended active ingredients inside a liquid phase with zero mechanical pressure. Upon thermal transition at body temperature, the polymer lattice contracts tightly around the encapsulated molecules, creating a controlled diffusion barrier. This temperature-triggered gate holds room-temperature (22°C) API burst leakage under 0.5% over 24 hours, ensuring sustained zero-order or first-order drug release profiles only after physical contact with human skin.

     

  • Thermally Reversible Hydrophobic Association (Pain-Free Cold Wash Removal) 

    Removing adherent gel dressings from fragile granulating wound beds or burned tissue frequently strips newly formed epidermal cells, causing intense pain. Because our matrix relies on non-covalent hydrophobic interactions rather than permanent chemical cross-links, the phase transition is 100% thermally reversible. Flushing the solid gel with a sterile saline solution cooled to 10°C--15°C cools the interface below its LCST, instantly reverting the solid gel back into a smooth liquid precursor that washes away cleanly without mechanical pulling or tissue trauma.

 

B2B Procurement & Downstream Deployments

 

Targeted API & Transdermal Delivery Formulations

Supplied in temperature-controlled bulk carboys or pre-filled syringes to pharmaceutical and cosmeceutical developers integrating active peptides, growth factors, or small-molecule drugs for controlled topical delivery.

 

Irregular Deep-Cavity & Burn Wound Dressings

Pre-sterilized temperature-sensitive fluid gels supplied to advanced wound care packagers for treating Stage III/IV pressure ulcers, tunneled wounds, and partial-thickness burns.

 

Injectable Bio-Scaffolds & Tissue Engineering Matrices

High-purity, biocompatible thermoresponsive precursors supplied to biotechnology firms and medical research laboratories for 3D cell encapsulation, cartilage repair, and tissue regeneration scaffolds.

Precision Packaging & Cold-Chain Logistics Routing

 

  • Cold-Chain Hermetic Pouching & Barrier Syringes : Thermoresponsive precursors must remain below their LCST during storage and transit to prevent irreversible polymer aggregation. Pre-filled dual-chamber syringes and tubes are desiccant-packed inside zero-MVTR AL/PE foil pouches and shipped under strict 2°C--8°C cold-chain protocols with integrated temperature-logger indicators. 

  • Transnational Supply Resilience : Polymer block synthesis, temperature-controlled fluid compounding, and vacuum degassing execute natively inside our primary China facility. Sterile low-temperature syringe filling, primary packaging, and export palletization route through our Vietnam hub, protecting global B2B procurement networks from regional chemical/medical tariffs.

 

Quality & Compliance Systems

 

  • ISO 10993 Biocompatibility Clearance : Cured hydrogel lots undergo continuous independent laboratory testing against strict ISO 10993-5 (Cytotoxicity Grade 0), ISO 10993-10 (Sensitization), and ISO 10993-23 (Primary Dermal Irritation Index <0.1) boundaries, confirming zero skin allergy or cellular toxicity. 

  • MDSAP & ISO 13485 Manufacturing : Polymerization, temperature-controlled compounding, and cleanroom filling bays function strictly under ISO 13485:2016 and MDSAP regulatory frameworks, delivering unbroken lot-serialization from raw monomer chemicals to outbound cold-chain shipping pallets.

 

Technical FAQ

Q: How does the LCST phase transition of thermoresponsive hydrogels differ from conventional chemical or ionic cross-linking?

A: Conventional hydrogels rely on permanent covalent bonds or ionic cross-linkers that fix the polymer shape irreversibly during manufacturing. Thermoresponsive hydrogels rely on temperature-dependent non-covalent interactions (hydrogen bonding vs. hydrophobic interaction). Below the LCST, water molecules form a structured hydration shell around the polymer, keeping it liquid. Above the LCST, thermal motion breaks this hydration shell, forcing hydrophobic polymer chains to associate physically into a solid network without chemical cross-linking agents or light triggers.

Q: Can the LCST phase transition temperature be custom-tuned for ambient tropical storage or specific clinical applications?

A: Yes. The LCST is dictated by the precise ratio of hydrophilic to hydrophobic monomers in the copolymer backbone. By adjusting the molar ratio of isopropyl/propylene oxide domains or adding hydrophilic co-monomers (such as acrylic acid or PEG blocks), we can custom-shift the phase transition threshold anywhere between 28.0°C and 38.0°C to match specific storage protocols, tropical ambient conditions, or internal body cavity temperatures.

Pharmaceutical R&D networks, wound care brand owners, and tissue engineering developers can request LCST differential scanning calorimetry (DSC) reports, rheological temperature-sweep datasheets, and trial evaluation precursor samples. 

👉 [Request Thermoresponsive Hydrogel Samples]

 

Hot Tags: thermoresponsive hydrogel, China thermoresponsive hydrogel manufacturers, suppliers, factory, Hydrogel, Medical Hydrogel

Technical Specifications

 

Thermodynamic Parameter Target Baseline  Testing Standard 
Phase Transition Temperature (LCST) 32.0°C - 35.5°C Differential Scanning Calorimetry (DSC) 
Sol-to-Gel Transition Time  < 45 seconds at  37°C Rheological oscillation sweep 
Ambient Viscosity (20°C)  1,200 - 2,500 cPs Low-viscosity flowability for injection 
Storage Modulus (G' at  37°C) > 25,000  Pa Post-transition structural integrity 
Room-Temp API Burst Leakage  < 0.5% over 24h at  22°C Temperature-locked encapsulation assay 
Send Inquiry